A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new weight loss drug
qz.com › cagrisema-ozempic-weight-loss-drug-novo-nordisk-1851696433
This story seems to be about:
This story seems to be about:
Novo Nordisk (NVO) — the company credited with ushering in the current weight-loss drug revolution when it launched its blockbuster diabetes treatment Ozempic in 2017 — is working on its next act, a weight-loss drug called CagriSema